We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
Varian gets FDA IDE approval to begin clinical trial of FLASH therapy
The study will assess Varian’s ProBeam particle accelerator modified to deliver an advanced non-invasive treatment for cancer patients. (Credit: Bokskapet from Pixabay)